Multiple Endocrine Neoplasia and Hyperparathyroid-Jaw Tumor Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood

Autor: Wasserman JD, Tomlinson GE, Druker H, Kamihara J, Kohlmann WK, Kratz CP, Nathanson KL, Pajtler KW, Parareda A, Rednam SP, States LJ, Villani A, Walsh MF, Zelley K, Schiffman JD

Publikováno v: CLINICAL CANCER RESEARCH
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu

Children and adolescents who present with neuroendocrine tumors are at extremely high likelihood of having an underlying germline predisposition for the multiple endocrine neoplasia (MEN) syndromes, including MEN1, MEN2A and MEN2B, MEN4, and hyperpar

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::e452e649ffdb8f66db32e871fd63400f
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=12679

Update on surveillance guidelines in emerging Wilms tumor predisposition syndromes.

Autor: Brzezinski JJ; Hospital for Sick Children, Toronto, Canada., Becktell KD; Medical College of Wisconsin, Milwaukee, WI, United States., Bougeard G; University of Rouen Normandy and Inserm U1245 and CHU Rouen, Rouen, France., Brodeur GM; Children's Hospital of Philadelphia, Philadelphia, PA, United States., Diller LR; Dana-Farber Cancer Institute, Boston, MA, United States., Doria AS; Hospital for Sick Children, Canada., Hansford JR; South Australian Health and Medical Research Institute, Adelaide, SA, Australia., Kohlmann WK; University of Utah, Salt Lake City, UT, United States., Kratz CP; Hannover Medical School, Hannover, Germany., MacFarland SP; Children's Hospital of Philadelphia, Philadephia, PA, United States., Pajtler KW; German Cancer Research Center, Heidelberg, Germany., Rednam SP; Baylor College of Medicine, Houston, TX, United States., Schienda J; Dana-Farber Cancer Institute, Boston, MA, United States., States LJ; Children's Hospital of Philadelphia, Philadelphia, PA, United States., Villani A; Hospital for Sick Children, Toronto, Ontario, Canada., Weksberg R; Hospital for Sick Children, Toronto, State, Canada., Zelley K; Children's Hospital of Philadelphia, Philadelphia, PA, United States., Tomlinson GE; The University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States., Kalish JM; Children's Hospital of Philadelphia, Philadelphia, PA, United States.

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Oct 28. Date of Electronic Publication: 2024 Oct 28.

Update on Cancer Predisposition Syndromes and Surveillance Guidelines for Childhood Brain Tumors.

Autor: Hansford JR; Michael Rice Children's Hematology and Oncology Center, Women's and Children's Hospital; South Australia Health and Medical Research Institute; South Australia ImmunoGenomics Cancer Institute, University of Adelaide, Adelaide, South Australia, Australia., Das A; Division of Hematology/Oncology, The Hospital for Sick Children; SickKids Research Institute; Department of Pediatrics, University of Toronto, Toronto, Ontario, Canada., McGee RB; Department of Oncology, Division of Cancer Predisposition, St. Jude Children's Research Hospital, Memphis, Tennessee., Nakano Y; Department of Pediatrics, Division of Hematology/Oncology, Baylor College of Medicine, Houston, Texas., Brzezinski J; Division of Hematology/Oncology, The Hospital for Sick Children; SickKids Research Institute; Department of Pediatrics, University of Toronto, Toronto, Ontario, Canada., Scollon SR; Department of Pediatrics, Division of Hematology/Oncology, Baylor College of Medicine, Houston, Texas., Rednam SP; Department of Pediatrics, Division of Hematology/Oncology, Baylor College of Medicine, Houston, Texas., Schienda J; Department of Pediatric Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts., Michaeli O; Division of Hematology/Oncology, Schneider Children's Medical Center of Israel, Petach Tikva, Israel., Kim SY; Division of Human Genetics, Department of Pediatrics, Cincinnati Children's Hospital Center, Cincinnati, Ohio., Greer MC; Department of Diagnostic and Interventional Radiology, The Hospital for Sick Children/Department of Medical Imaging, University of Toronto, Toronto, Ontario, Canada., Weksberg R; Division of Clinical and Metabolic Genetics, Department of Pediatrics, Hospital for Sick Children and University of Toronto, Toronto, Ontario, Canada., Stewart DR; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland., Foulkes WD; Department of Human Genetics, McGill University, and Division of Medical Genetics, Departments of Specialized Medicine, McGill University Health Centre and Jewish General Hospital, Montreal, Quebec, Canada., Tabori U; Division of Hematology/Oncology, The Hospital for Sick Children; SickKids Research Institute; Department of Pediatrics, University of Toronto, Toronto, Ontario, Canada., Pajtler KW; Division of Pediatric Neurooncology, Hopp Children's Cancer Center Heidelberg (KiTZ); German Cancer Research Center Heidelberg (DKFZ) and Heidelberg University Hospital, Heidelberg; National Center for Tumor Diseases (NCT), Heidelberg, Germany., Pfister SM; Division of Pediatric Neurooncology, Hopp Children's Cancer Center Heidelberg (KiTZ); German Cancer Research Center Heidelberg (DKFZ) and Heidelberg University Hospital, Heidelberg; National Center for Tumor Diseases (NCT), Heidelberg, Germany., Brodeur GM; Department of Pediatrics, Division of Oncology, the Children's Hospital of Philadelphia, and the University of Pennsylvania/Perelman School of Medicine, Philadelphia, Pennsylvania., Kamihara J; Department of Pediatric Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts.

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Jun 03; Vol. 30 (11), pp. 2342-2350.

Combined Bioinformatic and Splicing Analysis of Likely Benign Intronic and Synonymous Variants Reveals Evidence for Pathogenicity.

Autor: Hirschi OR; Baylor College of Medicine, Houston, Texas.; Texas Children's Cancer Center, Texas Children's Hospital, Houston, Texas., Felker SA; HudsonAlpha Institute for Biotechnology, Huntsville, Alabama., Rednam SP; Baylor College of Medicine, Houston, Texas.; Texas Children's Cancer Center, Texas Children's Hospital, Houston, Texas., Vallance KL; HudsonAlpha Institute for Biotechnology, Huntsville, Alabama., Parsons DW; Baylor College of Medicine, Houston, Texas.; Texas Children's Cancer Center, Texas Children's Hospital, Houston, Texas., Roy A; Baylor College of Medicine, Houston, Texas., Cooper GM; HudsonAlpha Institute for Biotechnology, Huntsville, Alabama., Plon SE; Baylor College of Medicine, Houston, Texas.; Texas Children's Cancer Center, Texas Children's Hospital, Houston, Texas.

Publikováno v: MedRxiv : the preprint server for health sciences [medRxiv] 2023 Nov 01. Date of Electronic Publication: 2023 Nov 01.

Gadolinium is not necessary for surveillance MR imaging in children with chiasmatic-hypothalamic low-grade glioma.

Autor: Malbari F; Department of Pediatrics, Division of Neurology and Developmental Neurosciences, Texas Children's Hospital, Houston, Texas., Chintagumpala MM; Texas Children's Cancer Center, Baylor College of Medicine, Houston, Texas., Wood AC; USDA/ARS Children's Nutrition Research Center, Baylor College of Medicine, Department of Pediatrics, Baylor College of Medicine, Houston, Texas., Levy AS; Department of Pediatrics, Division of Hematology Oncology and Marrow and Blood Cell Transplantation, Children's Hospital at Montefiore, Bronx, New York., Su JM; Texas Children's Cancer Center, Baylor College of Medicine, Houston, Texas., Okcu MF; Texas Children's Cancer Center, Baylor College of Medicine, Houston, Texas., Lin FY; Texas Children's Cancer Center, Baylor College of Medicine, Houston, Texas., Lindsay H; Texas Children's Cancer Center, Baylor College of Medicine, Houston, Texas., Rednam SP; Texas Children's Cancer Center, Baylor College of Medicine, Houston, Texas., Baxter PA; Texas Children's Cancer Center, Baylor College of Medicine, Houston, Texas., Paulino AC; Department of Radiation Oncology, Division of Radiation Oncology, MD Anderson Cancer Center, Houston, Texas., Orzaiz GA; Department of Pediatrics, Division of Neurosurgery, Texas Children's Hospital, Houston, Texas., Whitehead WE; Department of Pediatrics, Division of Neurosurgery, Texas Children's Hospital, Houston, Texas., Dauser R; Department of Pediatrics, Division of Neurosurgery, Texas Children's Hospital, Houston, Texas., Supakul N; Department of Clinical Radiology and Imaging Sciences, Indiana University Health, Indianapolis, Indiana., Kralik SF; Department of Pediatrics, Division of Radiology, Texas Children's Hospital, Houston, Texas.

Publikováno v: Pediatric blood & cancer [Pediatr Blood Cancer] 2021 Oct; Vol. 68 (10), pp. e29178. Date of Electronic Publication: 2021 Jun 16.